Publication

Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis

Diabetes 69(6):1090-1099, 2020

Suppli MP, Bagger JI, Lund A, Demant M, van Hall G, Strandberg C, Kønig MJ, Rigbolt K, Langhoff JL, Albrechtsen NJW, Holst JJ, Vilsbøll T, Knop FK

View publication

Share this page

Resource Library

Related resources

Characterization of lanifibranor treatment in the non-obese CDAA-HFD mouse model of advanced NASH with progressive fibrosis

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

Metabolic, biochemical and histological effects of elafibranor in a CDAA-HFD induced non-obese rat model of advanced NASH with progressive fibrosis

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650